HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoko Ito Selected Research

Naoko Ito Research Topics

Disease

5Multiple Sclerosis
01/2022 - 10/2008
4Inflammation (Inflammations)
12/2023 - 01/2014
4Neoplasms (Cancer)
08/2023 - 05/2007
3Immunoglobulin G4-Related Disease
02/2024 - 01/2011
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 07/2011
3Autoimmune Diseases (Autoimmune Disease)
12/2020 - 01/2014
2Dysbiosis
01/2022 - 10/2017
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 01/2014
2Relapsing-Remitting Multiple Sclerosis
02/2021 - 01/2014
2Demyelinating Diseases (Demyelinating Disease)
02/2021 - 01/2014
2Disease Progression
04/2016 - 01/2014
2Chronic Renal Insufficiency
12/2014 - 08/2014
2Anemia
08/2014 - 01/2009
2Glucose Intolerance
01/2014 - 07/2011
2Liver Cirrhosis (Hepatic Cirrhosis)
05/2013 - 01/2009
2Wounds and Injuries (Trauma)
07/2006 - 03/2002
1Membranous Glomerulonephritis (Membranous Nephropathy)
02/2024
1Interstitial Nephritis (Tubulointerstitial Nephritis)
02/2024
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
12/2023
1Hypertrophy
12/2023
1Mitochondrial encephalopathy
11/2023
1MELAS Syndrome (Syndrome, MELAS)
11/2023
1Lactic Acidosis
11/2023
1Stroke (Strokes)
11/2023
1Respiratory Insufficiency (Respiratory Failure)
08/2023
1Body Weight (Weight, Body)
01/2021
1Heart Failure
01/2021
1Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome)
05/2018
1Hypoglycemia (Reactive Hypoglycemia)
01/2018
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
08/2017
1Glomerulonephritis
08/2017
1Atypical Hemolytic Uremic Syndrome
04/2016
1Pericardial Effusion
12/2015
1Human Influenza (Influenza)
12/2015
1Myocarditis (Carditis)
12/2015
1Pericarditis
12/2015
1Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
11/2015
1Hypokalemia
11/2015
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2015
1Esophageal Neoplasms (Esophageal Cancer)
09/2014
1Squamous Cell Neoplasms (Squamous Cell Cancer)
09/2014

Drug/Important Bio-Agent (IBA)

4Myelin Basic ProteinIBA
01/2022 - 10/2008
3Immunoglobulin G (IgG)IBA
02/2024 - 01/2011
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 07/2011
2Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2007
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 10/2017
2Complement C3 (C3 Complement)IBA
02/2021 - 10/2017
2Darbepoetin alfa (Aranesp)FDA Link
12/2014 - 08/2014
2Triglycerides (Triacylglycerol)IBA
01/2013 - 07/2011
2jasmonic acid (jasmonate)IBA
07/2006 - 03/2002
2Protein Kinases (Protein Kinase)IBA
07/2006 - 03/2002
1nephrinIBA
12/2023
1AntibodiesIBA
12/2023
1CreatinineIBA
12/2023
1Mitochondrial DNA (mtDNA)IBA
11/2023
1SynaptophysinIBA
08/2023
1Prednisolone (Predate)FDA LinkGeneric
08/2023
1Chromogranin AIBA
08/2023
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2022
1Environmental BiomarkersIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2022
1Lipocalin-2IBA
01/2022
1Glatiramer Acetate (Copaxone)FDA Link
07/2021
1Dimethyl FumarateIBA
02/2021
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2021
1LiraglutideFDA Link
01/2021
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2020
1Dichlororibofuranosylbenzimidazole (DRB)IBA
12/2020
1EpitopesIBA
12/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2018
1AnaphylatoxinsIBA
10/2017
1AutoantigensIBA
10/2017
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2017
1Dichlorodiphenyldichloroethane (DDD)IBA
08/2017
1eculizumabFDA Link
04/2016
1CytokinesIBA
12/2015
1Zanamivir (Relenza)FDA Link
12/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2015
1InterferonsIBA
12/2015
1InterleukinsIBA
12/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015
1ChemokinesIBA
12/2015
1Neuraminidase (Sialidase)IBA
12/2015
1dirhodium tetraacetate (DRTA)IBA
11/2015
1Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA
11/2015
1ChloridesIBA
11/2015
1Bicarbonates (Hydrogen Carbonate)IBA
11/2015
1ochratoxin AIBA
01/2015
1AflatoxinsIBA
01/2015
1Blood Glucose (Blood Sugar)IBA
09/2014

Therapy/Procedure

6Therapeutics
12/2015 - 05/2007
2Hepatectomy
12/2013 - 10/2013
2Drug Therapy (Chemotherapy)
11/2013 - 11/2011
1Transplantation
12/2023
1Ligation
05/2018
1Glycemic Control
01/2018
1Esophagectomy
09/2014
1Laparotomy
09/2014